MEDTRONIC - 4504M
by Medtronic Cardiac Rhythm Disease Management
PMA P830061
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP830061 | Date29 Jul 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade Name
- Steroid Tip(Tm) Model 4503&4003 Transvenous Pacing
- Generic Name
- Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
- PMA Number
- FDA Product Code
- NVN
- Models / Variants
- 4504M
- Device Class
- Class III
- Advisory Committee
- Cardiovascular
- FDA Decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
These devices are drug-eluting permanent transvenous pacemaker electrodes designed for implantation in the right ventricular (RV) or right atrial (RA) chambers. They provide pacing stimulation to regulate cardiac rhythm in patients with bradycardia or conduction system disorders, delivering consistent electrical impulses via a steroid-eluting tip to reduce tissue inflammation and improve electrode stability.
The electrodes are supplied sterile and intended for single-use implantation by qualified healthcare professionals in clinical settings such as cardiac catheterization labs or operating rooms. They are classified as Class III devices under FDA regulations and require a Premarket Approval (PMA) (P830061). Compatibility with MRI is not specified, and proper storage adheres to manufacturer guidelines to maintain sterility and functionality. Sizes and configurations are standardized for transvenous placement via venous access.
Other devices from Medtronic Cardiac Rhythm Disease Management
See all devices from Medtronic Cardiac Rhythm Disease Management →
Questions
AI-generated answers, 18 Sep 2026
What specific cardiac chambers are these pacemaker electrodes designed to be implanted in, and how do they differ in function between those chambers?
These electrodes are designed for implantation in either the **right ventricular (RV)** or **right atrial (RA)** chambers. The primary function remains pacing stimulation to regulate bradycardia or conduction disorders, but the placement differs: RV electrodes target the lower heart chamber to stimulate ventricular contractions, while RA electrodes target the upper chamber to stimulate atrial contractions. Both models feature a **steroid-eluting tip** to reduce tissue inflammation and improve electrode stability, ensuring consistent pacing regardless of chamber placement.
Are these electrodes reusable, or are they intended for single-use only? What does this mean for clinical workflows?
These electrodes are **intended for single-use only** and are supplied sterile for implantation by qualified healthcare professionals. This design ensures patient safety by eliminating risks associated with reuse, such as infection or degradation of electrode performance. Clinically, this means each electrode must be opened and used immediately in a controlled setting like a cardiac catheterization lab or operating room, with proper disposal following use.
What storage requirements must be followed to maintain sterility and functionality of these electrodes?
The electrodes must be stored according to **manufacturer guidelines** to preserve sterility and functionality. Since they are supplied sterile, they should remain in their original packaging until ready for use, protected from contamination, moisture, or physical damage. Exposure to extreme temperatures or prolonged storage beyond the specified shelf life could compromise performance, so adherence to the packaging instructions is critical.
How do the steroid-eluting tips on these electrodes benefit patients compared to non-steroid-eluting models?
The **steroid-eluting tip** reduces tissue inflammation at the implantation site, which helps minimize fibrosis (scarring) around the electrode. This improves long-term electrode stability and pacing consistency, reducing the likelihood of lead dislodgment or failure over time. For patients, this can translate to fewer complications and a lower risk of requiring reoperation or lead revision.
What should clinicians consider regarding MRI compatibility when using these electrodes?
The **MRI compatibility** of these electrodes is **not specified** in the provided data. Clinicians should consult Medtronic’s official guidelines or documentation for the specific models (4003M, 4503M, 4504M, or 4523) before exposing patients to MRI scans. If MRI is required, alternative imaging modalities or precautions may need to be taken to avoid potential risks to the patient or device.